Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Virus Inactivation | 2 | 2021 | 1139 | 0.87 | Why? |
| Herpesvirus Vaccines | 1 | 2018 | 9 | 0.79 | Why? |
| Cytomegalovirus Infections | 4 | 2018 | 667 | 0.78 | Why? |
| Calcium Phosphates | 1 | 2018 | 35 | 0.76 | Why? |
| Cytomegalovirus | 4 | 2018 | 600 | 0.76 | Why? |
| Glycyrrhizic Acid | 1 | 2021 | 190 | 0.74 | Why? |
| Retinitis | 1 | 2017 | 42 | 0.68 | Why? |
| Acyclovir | 1 | 2017 | 154 | 0.65 | Why? |
| Herpesviridae | 1 | 2017 | 100 | 0.64 | Why? |
| Herpesvirus 1, Human | 2 | 2018 | 286 | 0.63 | Why? |
| Virus Activation | 2 | 2018 | 480 | 0.63 | Why? |
| Ultraviolet Rays | 2 | 2021 | 1272 | 0.54 | Why? |
| Blood Donors | 3 | 2021 | 2956 | 0.42 | Why? |
| Disinfection | 2 | 2021 | 2912 | 0.42 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.41 | Why? |
| Hepatitis B | 2 | 2017 | 888 | 0.39 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.37 | Why? |
| Immunoassay | 3 | 2018 | 4485 | 0.33 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.32 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.32 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.28 | Why? |
| Immunity, Cellular | 5 | 2021 | 3614 | 0.27 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.26 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.26 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.26 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.24 | Why? |
| Hepatitis C | 1 | 2013 | 1514 | 0.23 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.23 | Why? |
| Immunization, Passive | 4 | 2021 | 10067 | 0.23 | Why? |
| Interferon-gamma | 4 | 2020 | 2711 | 0.22 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.21 | Why? |
| Plant Roots | 1 | 2021 | 108 | 0.21 | Why? |
| Drug Resistance, Viral | 2 | 2017 | 1083 | 0.21 | Why? |
| Glycyrrhiza | 1 | 2021 | 141 | 0.20 | Why? |
| Pasteurization | 1 | 2020 | 102 | 0.20 | Why? |
| Cosmetics | 1 | 2021 | 100 | 0.20 | Why? |
| Hepatitis D, Chronic | 1 | 2019 | 16 | 0.20 | Why? |
| Antiviral Agents | 8 | 2021 | 41703 | 0.19 | Why? |
| Hepatitis Delta Virus | 1 | 2019 | 54 | 0.19 | Why? |
| Immunologic Surveillance | 1 | 2019 | 69 | 0.19 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.18 | Why? |
| HLA-B Antigens | 1 | 2019 | 166 | 0.17 | Why? |
| Hepatitis D | 1 | 2017 | 48 | 0.17 | Why? |
| Mice, Inbred BALB C | 2 | 2018 | 5814 | 0.17 | Why? |
| Simplexvirus | 1 | 2017 | 124 | 0.17 | Why? |
| HLA-A Antigens | 1 | 2019 | 196 | 0.17 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.15 | Why? |
| Mouthwashes | 1 | 2020 | 432 | 0.15 | Why? |
| Cell Survival | 1 | 2021 | 1581 | 0.15 | Why? |
| Enzyme-Linked Immunospot Assay | 3 | 2021 | 325 | 0.14 | Why? |
| Herpes Simplex | 1 | 2017 | 272 | 0.14 | Why? |
| Superinfection | 1 | 2019 | 459 | 0.13 | Why? |
| Hepatitis C Antibodies | 1 | 2013 | 120 | 0.13 | Why? |
| HIV Antigens | 1 | 2013 | 102 | 0.13 | Why? |
| Animals | 8 | 2021 | 78931 | 0.13 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.13 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.12 | Why? |
| Polymers | 1 | 2017 | 507 | 0.12 | Why? |
| Nucleic Acids | 1 | 2017 | 435 | 0.12 | Why? |
| Hepatitis B, Chronic | 1 | 2019 | 616 | 0.12 | Why? |
| Hepatitis B Surface Antigens | 1 | 2013 | 305 | 0.11 | Why? |
| Milk, Human | 1 | 2020 | 956 | 0.11 | Why? |
| Immunity, Humoral | 3 | 2021 | 4849 | 0.11 | Why? |
| Transplant Recipients | 2 | 2018 | 4982 | 0.11 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2019 | 5837 | 0.11 | Why? |
| Automation, Laboratory | 1 | 2013 | 536 | 0.11 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.10 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.10 | Why? |
| Germany | 3 | 2021 | 9196 | 0.09 | Why? |
| Mice | 2 | 2018 | 21357 | 0.09 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.09 | Why? |
| Immune Evasion | 1 | 2018 | 2081 | 0.09 | Why? |
| HIV Infections | 1 | 2013 | 11620 | 0.09 | Why? |
| HIV Antibodies | 1 | 2013 | 776 | 0.08 | Why? |
| DNA, Viral | 1 | 2018 | 2521 | 0.08 | Why? |
| Caco-2 Cells | 2 | 2020 | 1236 | 0.08 | Why? |
| Clinical Laboratory Techniques | 1 | 2013 | 23402 | 0.08 | Why? |
| Humans | 22 | 2021 | 930598 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.07 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.06 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.05 | Why? |
| High-Throughput Screening Assays | 2 | 2018 | 1783 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Adsorption | 1 | 2018 | 261 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Aged | 5 | 2021 | 215776 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.04 | Why? |
| Male | 7 | 2021 | 367725 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Neutralization Tests | 2 | 2020 | 6698 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.03 | Why? |
| Immune Tolerance | 1 | 2019 | 608 | 0.03 | Why? |
| Neutropenia | 1 | 2017 | 388 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
| Cell Line | 2 | 2019 | 12040 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2019 | 1074 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2017 | 1394 | 0.03 | Why? |
| Anemia | 1 | 2017 | 789 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2019 | 2262 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Virus Internalization | 1 | 2018 | 7921 | 0.01 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
Krawczyk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(107)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_